Kilitch Drugs Opens Nutraceutical Unit at Raigad Plant

RAIGAD, Maharashtra — Kilitch Drugs (India) Ltd. has officially commenced manufacturing operations at its newly constructed nutraceutical block located within its production complex in Village Maldev, Pen, Raigad district. This development is part of the company's broader ₹100 crore expansion roadmap, aimed at diversifying its product portfolio beyond traditional pharmaceutical formulations.

The new facility, situated along the Pen-Khopoli Highway, represents a strategic move for the Mumbai-based manufacturer. The company, which has historically specialized in injectables, ophthalmic formulations, and nasal solutions, is now aggressively expanding into the high-growth nutraceutical and dietary supplement segment to capture increasing domestic and export demand.

Strengthening Manufacturing Capabilities

The Raigad complex, which sits on a 15-acre land parcel, was envisioned as a state-of-the-art greenfield facility. According to company filings, the site is designed to house multiple manufacturing units across various therapeutic categories. The commencement of the nutraceutical block is the latest phase in this project, which aims to leverage modern engineering standards to meet global regulatory requirements.

"We are on a growth trajectory and demand for our products is increasing," Mukund Mehta, Chairman & Managing Director of Kilitch Drugs, previously stated regarding the company’s expansion plans. The investment is intended to fuel long-term revenue growth, with the company eyeing significant opportunities in both the Indian market and its strongholds across 26 African nations.

Diversification into Nutraceuticals

The entry into nutraceutical manufacturing allows Kilitch Drugs to cater to the evolving healthcare landscape, where preventive care and dietary supplementation have gained significant consumer traction. By utilizing its existing expertise in pharmaceutical manufacturing and combining it with dedicated nutraceutical production lines, the firm aims to enhance its product mix.

The facility’s design prioritizes international standards to ensure that products manufactured in Raigad are eligible for entry into highly regulated global markets. This alignment with global compliance is expected to bolster the company’s export-oriented business model.

Impact on Stakeholders

For investors, the operationalization of the nutraceutical block is a key indicator of execution progress regarding the company’s multi-year capital expenditure plan. For the local economy in Raigad, the project contributes to industrial development and job creation in the Pen-Khopoli region. Furthermore, consumers can expect a wider range of high-quality nutritional solutions as the company scales its production capacity in the coming quarters.

Key Facts at a Glance

• Location: The new manufacturing block is located at the Kilitch Drugs complex in Village Maldev, Pen, Raigad, Maharashtra.

• Strategic Shift: The company is expanding from traditional injectables into nutraceuticals and dietary supplements.

• Expansion Scope: The broader Raigad project encompasses 15 acres and is part of a ₹100 crore capital expenditure program.

• Operational Focus: The new unit is designed to meet stringent global regulatory standards to facilitate both domestic distribution and international exports.

FAQ

What kind of products will be manufactured at the new Raigad block?

The new block is dedicated to nutraceuticals and dietary supplements, reflecting the company’s shift toward preventive healthcare and diversified wellness products.

How does this expansion fit into Kilitch Drugs’ overall growth strategy?

The Raigad expansion is a core component of the company’s ₹100 crore investment plan to increase manufacturing capacity and revenue potential by setting up multiple units across therapeutic categories.

Does Kilitch Drugs have other manufacturing facilities?

Yes, in addition to its operations in India, the company maintains significant manufacturing infrastructure, including a large-scale plant in Ethiopia dedicated to Cephalosporin products.

Source: Kilitch Drugs (India) Ltd. Official Filings, Business Standard, India Infoline